Long-Term Investigative Follow-Up in TrialNet Study

The LIFT Study is available nationwide to TrialNet participants who either:

- Developed diabetes while being monitored in the Pathway to Prevention Study or during participation in any prevention trial. The purpose is to study people early in the disease process

- Participated in any new onset studies. The purpose is to learn more about diabetes and if there are any long-term effects—good or bad—from the treatments used in these studies

Participants will be asked to return to a TrialNet site annually or semi- annually, based on their ongoing ability to produce insulin. Visits will include metabolic testing (i.e., Oral Glucose Tolerance Test and/or Mixed Meal Tolerance Test), HbAc1, and possibly other blood or urine tests.